Abstract
The Biopharmaceutics Classification System is a drug development tool that estimates the contributions of solubility, dissolution, and intestinal permeability affecting drug absorption from solid oral products. A regulatory guidance proposes human, animal, and in vitro methods to determine the permeability class membership of a drug substance. Method suitability is a process to establish and validate cellular or tissue permeability assays for classification of drug substances. It consists of establishing an assay with comparison of experimental permeability to in vivo extent of absorption, defining reference standards and acceptance criteria, and classifying new drug substances. Literature examples with cells, intestinal tissue, and artificial membranes demonstrate the applicability and feasibility of method suitability for evaluating permeability models. An assay with established method suitability, standard compounds, and criteria for classifying drugs improves the reliability for such assays for regulatory applications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Volpe, D. (2008). Drug Permeability Studies in Regulatory Biowaiver Applications. In: Ehrhardt, C., Kim, KJ. (eds) Drug Absorption Studies. Biotechnology: Pharmaceutical Aspects, vol VII. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-74901-3_28
Download citation
DOI: https://doi.org/10.1007/978-0-387-74901-3_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-74900-6
Online ISBN: 978-0-387-74901-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)